Sector & Market
Edwards Lifesciences Shares Jump 3.6% on TAVR
Edwards Lifesciences stock rose 3.6% after U.S. government issued a National Coverage Decision proposal expanding TAVR coverage.
The memo adds coverage for asymptomatic severe aortic stenosis, removes
